Ranking Invest

MoonLake Immunotherapeutics

Segmento: Healthcare MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.

Indicadores Básicos

Valor de Mercado

$ 3.34 Bi

IVR

0.05

IVR2

-0.08

Índices de Previsibilidade

Faturamento

1.54

Lucro

0.64

Margem

1.27

Índices de Tendência

Faturamento

2.38

Lucro

-6.31

Margem

-4.58

Índices de Endividamento

DIV/PAT

-0.49

DIV/L4T

1.35

Dívida Líquida

-$ 195.97 Mi

Patrimônio Líquido

$ 402.46 Mi

L4T

-$ 145.51 Mi

MM4T

-11194.04%

Dívidas
Dividendos
Cotação: $52.66

Não há dados de histórico de dividendos para exibir.

Gráfico Lucro/Faturamento X Trimestre